Bacteremia caused by Salmonella enterica serotype Choleraesuis in Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 39, Issue 5, 2006, Pages 358-365

  Jean, Shio Shin ^a   Wang, Jen Yu ^b   Hsueh, Po Ren ^c  

^a MIN SHENG GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Beta lactamases; Cephalosporins; Fluoroquinolones; Salmonella enterica; Vaccines

Indexed keywords

AMPICILLIN; BACTERIAL VACCINE; BETA LACTAMASE AMPC; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ENROFLOXACIN; PROTEIN PARC; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL GENE; CLINICAL FEATURE; DISEASE TRANSMISSION; GENE MUTATION; HUMAN; MYCOTIC ANEURYSM; NONHUMAN; PROPHYLAXIS; REVIEW; SALMONELLA CHOLERAESUIS; SALMONELLA ENTERICA; SALMONELLOSIS; SEPTICEMIA; TAIWAN;

ANEURYSM, INFECTED; ANIMALS; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EVOLUTION; FEVER; FLUOROQUINOLONES; HUMANS; PLASMIDS; PREVALENCE; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SPECIES SPECIFICITY; SWINE; TAIWAN; VIRULENCE; VIRULENCE FACTORS;

EID: 33845984899     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Altekruse SF, Cohen ML, Swerdlow DL. Emerging foodborne diseases. Emerg Infect Dis 1997;3:285-93.
2. Chan P, Tsai CW, Huang JJ, Chuang YC, Hung JS. Salmonellosis and mycotic aneurysm of the aorta. A report of 10 cases. J Infect 1995;30:129-33.
3. Sun HY, Tseng SP, Hsueh PR, Hung CC, Hsieh SM, Teng LJ, et al. Occurrence of ceftriaxone resistance in ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis isolates causing recurrent infection. Clin Infect Dis 2005;40:208-9.
4. Wang JY, Hwang JJ, Hsu CN, Lin LC, Hsueh PR. Bacteraemia due to ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis in adult patients at a university hospital in Taiwan, 1996-2004. Epidemiol Infect 2006;Mar 29:1-8.
5. Ko WC, Yan JJ, Yu WL, Lee HC, Lee NY, Wang LR, et al. A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis. Clin Infect Dis 2005;40:315-8.
6. Jean SS, Lee YT, Guo SM, Hsueh PR. Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem. J Infect 2005;51:e163-5.
7. Chen CW, Ko WC, Sung JM, Huang JJ. Ruptured mycotic aneurysm of the iliac artery complicated by emphysematous psoas muscle abscess: report of two cases. J Formos Med Assoc 2002;101:144-7.
8. Chiu CH, Su LH, Chu C, Chia JH, Wu TL, Lin TY, et al. Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin. Lancet 2004;363:1285-6.
9. Chiu S, Chiu CH, Lin TY. Salmonella enterica Serotype Choleraesuis infection in a medical center in northern Taiwan. J Microbiol Immunol Infect 2004;37:99-102.
10. Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of salmonella infections. Medicine (Baltimore) 1987;66:349-88.
11. Shimoni Z, Pitlik S, Leibovici L, Samra Z, Konigsberger H, Drucker M, et al. Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin Infect Dis 1999;28:822-7.
12. Chiu CH, Lin TY, Ou JT. Predictors for extraintestinal infection of non-typhoidal Salmonella in patients without AIDS. Int J Clin Pract 1999;53:161-4.
13. Chen YH, Chen TP, Tsai JJ, Hwang KP, Lu PL, Cheng HH, et al. Epidemiological study of human salmonellosis during 1991-1996 in southern Taiwan. Kaohsiung J Med Sci 1999;15:127-36.
14. Threlfall EJ, Hall ML, Rowe B. Salmonella bacteremia in England and Wales, 1981-1990. J Clin Pathol 1992;45:34-6.
15. Chiu CH, Lin TY, Ou JT. Age-related differences of nontyphoid Salmonella bacteremia in clinical presentation and outcome: association with specific serovars but not necessarily with the virulence plasmids. Clin Infect Dis 2000;30:239-41.
16. Su LH, Chiu CH, Kuo AJ, Chia JH, Sun CF, Leu HS, et al. Secular trends in incidence and antimicrobial resistance among clinical isolates of Salmonella at a university hospital in Taiwan, 1983-1999. Epidemiol Infect 2001;127:207-13.
17. Chen YH, Chen TP, Lu PL, Su YC, Hwang KP, Tsai JJ, et al. Salmonella choleraesuis bacteremia in southern Taiwan. Kaohsiung J Med Sci 1999;15:202-8.
18. Wang JH, Liu YC, Yen MY, Wang JH, Chen YS, Wann SR, et al. Mycotic aneurysm due to non-typhi salmonella: report of 16 cases. Clin Infect Dis 1996;23:743-7.
19. Chiu CH, Wu TL, Su LH, Liu JW, Chu C. Fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis. Taiwan. 2000-2003. Emerg Infect Dis 2004;10:1674-6.
20. Gray JT, Fedorka-Cray PJ. Survival and infectivity of Salmonella choleraesuis in swine feces. J Food Prot 2001;64:945-9.
21. Taylor RJ, Burrows MR. The survival of Escherichia coli and Salmonella dublin in a slurry on pasture and the infectivity of S. dublin for grazing calves. Br Vet J 1971;127:536-43.
22. Gray JT, Stabel TJ, Fedorka-Cray PJ. Effect of dose on the immune response and persistence of Salmonella choleraesuis in swine. Am J Vet Res 1996;57:313-9.
23. Heard TW, Linton AH. An epidemiological study of Salmonella in a closed pig herd. J Hyg (Lond) 1966;64:411-7.
24. Lee CY, Chiu CH, Chuang YY, Su LH, Wu TL, Chang LY, et al. Multidrug-resistant non-typhoid Salmonella infections in a medical center. J Microbiol Immunol Infect 2002;35:78-84.
25. Cohen M, Tauxe R. Drug-resistant Salmonella in the United States: an epidemiologic perspective. Science 1986;234:964-9.
26. Bauernfeind A, Casellas JM, Goldberg M, Holley M, Jungwirth R, Mangold P, et al. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection 1992;20:158-63.
27. Bradford PA, Yang Y, Sahm D, Grope I, Gardovska D, Storch G. CTX-M-5. a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Lativa. Antimicrob Agents Chemother 1998;42:1980-4.
28. Gazouli M, Tzelepi E, Sidorenko SV, Tzouvelekis LS. Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A beta-lactamase (CTX-M-4): involvement of serine 237 in cephalosporin hydrolysis. Antimicrob Agents Chemother 1998;42:1259-62.
29. Workman MR, Philpott-Howard J, Bragman S, Brito-Babapulle F, Bellingham AJ. Emergence of ciprofloxacin resistance during treatment of Salmonella osteomyelitis in three patients with sickle cell disease. J Infect 1996;32:27-32.
30. Shannon K, French G. Multiple-antibiotic-resistant salmonella. Lancet 1998;352:490.
31. Rankin SC, Coyne MJ. Multiple antibiotic resistance in Salmonella enterica Serotype Enteritidis. Lancet 1998;351:1740.
32. Fey PD, Safranek TJ, Rupp ME, Dunne EF, Ribot E, Iwen PC, et al. Ceftriaxone-resistant salmonella infection acquired by a child from cattle. N Engl J Med 2000;342:1242-9.
33. Chiu CH, Wu TL, Su LH, Chu C, Chia JH, Kuo AJ, et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N Engl J Med 2002;346:413-9.
34. Hsueh PR, Teng LJ, Tseng SP, Chang CF, Wan JH, Yan JJ, et al. Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg Infect Dis 2004;10:60-8.
35. Yan JJ, Ko WC, Chiu CH, Tsai SH, Wu HM, Wu JJ. Emergence of ceftriaxone-resistant Salmonella isolates and rapid spread of plasmid-encoded CMY-2-like cephalosporinase, Taiwan. Emerg Infect Dis 2003;9:323-8.
36. Chiu CH, Su LH, Chu C, Chia JH, Wu TL, Lin TY, et al. Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin. Lancet 2004;363:1285-6.
37. Chiu CH, Su LH, Chu C. Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment. Clin Microbiol Rev 2004;17:311-22.
38. Chang CC, Lin YH, Chang CF, Yeh KS, Chiu CH, Chu C, et al. Epidemiologic7 relationship between fluoroquinolone-resistant Salmonella enterica serovar Choleraesuis strains isolated from humans and pigs in Taiwan (1997 to 2002). J Clin Microbiol 2005;43:2798-804.
39. Yan JJ, Chiou CS, Lauderdale TL, Tsai SH, Wu JJ. Cephalosporin and ciprofloxacin resistance in Salmonella, Taiwan. Emerg Infect Dis 2005;11:947-50.
40. Yan JJ, Hong CY, Ko WC, Chen YJ, Tsai SH, Chuang CL, et al. Dissemination of blaCMY-2 among Escherichia coli isolates from food animals, retail ground meats, and humans in southern Taiwan. Antimicrob Agents Chemother 2004;48:1353-6.
41. Winokur PL, Vonstein DL, Hoffman LJ, Uhlenhopp EK, Doern GV. Evidence of transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob Agents Chemother 2001;45:2716-22.
42. Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, Chiu CH. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother 2005;55:846-52.
43. Zgurskaya HI, Nikaido H. Multidrug resistance mechanisms: drug efflux across two membranes. Mol Microbiol 2000;37:219-25.
44. Nikaido H, Basina M, Nguyen V, Rosenberg EY. Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains. J Bacteriol 1998;180:4686-92.
45. Casin I, Breuil J, Darchis JP, Guelpa C, Collatz E. Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica typhimurium isolates in humans. Emerg Infect Dis 2003;9:1455-7.
46. Travers K, Barza M. Morbidity of infections caused by antimicrobial-resistant bacteria. Clin Infect Dis 2002;34(Suppl 3):S131-4.
47. Lee LA, Puhr ND, Maloney EK, Bean NH, Tauxe RV. Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990. J Infect Dis 1994;170:128-34.
48. Holmberg SD, Wells JG, Cohen ML. Animal-to-man transmission of antimicrobial-resistant salmonella: investigations of U.S. outbreaks, 1971-1983. Science 1984;225:833-5.
49. Chu C, Chiu CH, Wu WY, Chu CH, Liu TP, Ou JT. Large drug resistance virulence plasmids of clinical isolates of Salmonella enterica serovar Choleraesuis. Antimicrob Agents Chemother 2001;45:2299-303.
50. Ashkenazi S, Cleary TG, Murray BE, Wanger A, Pickering LK. Quantitative analysis and partial characterization of cytotoxin production by Salmonella strains. Infect Immun 1988;56:3089-94.
51. Gulig PA, Curtiss R. Plasmid-associated virulence of Salmonella typhimurium. Infect Immun 1987;55:2891-901.
52. Guiney DG, Fang FC, Krause M, Libby S, Buchmeier NA, Fierer J. Biology and clinical significance of virulence plasmids in Salmonella serovars. Clin Infect Dis 1995;21 (Suppl 2):S146-51.
53. Friedrich MJ, Kinsey NE, Vila J, Kadner RJ. Nucleotide sequence of a 13.9 kb segment of the 90 kb virulence plasmid of Salmonella typhimurium: the presence of fimbrial biosynthetic genes. Mol Microbiol 1993;8:543-58.
54. Chiu CH, Tang P, Chu C, Hu S, Bao Q, Yu J, et al. The genome sequence of Salmonella enterica serovar Choleraesuis, a highly invasive and resistant zoonotic pathogen. Nucleic Acids Res 2005;33:1690-8.
55. Nnalue NA, Stocker BA. Test of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis. Infect Immun 1987;55:955-62.
56. Kelly SM, Bosecker BA, Curtiss R. Characterization and protective properties of attenuated mutants of Salmonella choleraesuis. Infect Immun 1992;60:4881-90.
57. Kennedy MJ, Yancey RJ Jr, Sanchez MS, Rzepkowski RA, Kelly SM, Curtiss R 3rd. Attenuation and immunogenicity of Deltacya Deltacrp derivatives of Salmonella choleraesuis in pigs. Infect Immun 1999;67:4628-36.